Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-02-01 @ 12:29 PM
Study NCT ID:
NCT04037358
Status:
COMPLETED
Last Update Posted:
2025-12-19
First Post:
2019-07-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
J18147
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None